Dialysis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Dialysis stocks.

Dialysis Stocks Recent News

Date Stock Title
May 31 LMAT Roth MKM resumes coverage of LeMaitre with buy rating
May 31 DVA DaVita: A Stellar Run With EPS Upside Likely Ahead, Downgrading On Valuation
May 31 SNY FDA Extends Review Deadline For Regeneron/Sanofi's Dupixent For 'Smoker's Lungs' Disease
May 31 OPK OPKO Health to Participate in the Jefferies Global Healthcare Conference
May 31 DVA DaVita (DVA) Hits 52-Week High: What's Aiding the Stock?
May 31 DVA Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
May 31 SNY FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
May 31 SNY Pharma Stock Roundup: JNJ, MRK M&A Deals, SNY, RHHBY Drugs' Priority Review & More
May 31 SNY Regeneron/ Sanofi say FDA has delayed Dupixent COPD label
May 31 SNY Press Release: Sanofi launches 2024 global Employee Stock Purchase Plan
May 31 SNY Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
May 31 SNY Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
May 31 SNY Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type 2 Inflammation
May 31 SNY Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with type 2 inflammation
May 30 MMSI Merit Medical (MMSI) Up 5% Since Last Earnings Report: Can It Continue?
May 30 DVA Reasons Why You Should Retain Avantor (AVTR) Stock for Now
May 30 SNY Press Release: Sanofi completes acquisition of Inhibrx, Inc.
May 30 FMS Fresenius Medical Care plans layoffs ahead of California plant closure
May 29 SNY VeeCon 2024 Speakers Announced: X CEO Linda Yaccarino, Content Creator Khaby Lame, Gary Vee Among Special Guests To Appear At Festival That Combines Business, Pop Culture, Web3
May 29 AMGN Amgen wins approval of first biosimilar of AstraZeneca's Soliris
Dialysis

In medicine, dialysis (from Greek διάλυσις, diàlysis, "dissolution"; from διά, dià, "through", and λύσις, lỳsis, "loosening or splitting") is the process of removing excess water, solutes, and toxins from the blood in people whose kidneys can no longer perform these functions naturally. This is referred to as renal replacement therapy.
Dialysis is used in patients with rapidly developing loss of kidney function, called acute kidney injury (previously called acute renal failure), or slowly worsening kidney function, called Stage 5 chronic kidney disease, (previously called chronic kidney failure and end-stage renal disease and end-stage kidney disease).
Dialysis is used as a temporary measure in either acute kidney injury or in those awaiting kidney transplant and as a permanent measure in those for whom a transplant is not indicated or not possible.In the United Kingdom and the United States, dialysis is paid for by the government for those who are eligible. The first successful dialysis was performed in 1943.
In research laboratories, dialysis technique can also be used to separate molecules based on their size. Additionally, it can be used to balance buffer between a sample and the solution "dialysis bath" or "dialysate" that the sample is in. For dialysis in a laboratory, a tubular semipermeable membrane made of cellulose acetate or nitrocellulose is used. Pore size is varied according to the size separation required with larger pore sizes allowing larger molecules to pass through the membrane. Solvents, ions and buffer can diffuse easily across the semipermeable membrane, but larger molecules are unable to pass through the pores. This can be used to purify proteins of interest from a complex mixture by removing smaller proteins and molecules.

Browse All Tags